Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Keating

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
ACS Medicinal Chemistry Letters|August 16, 2019
Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody-Drug Conjugates (ADCs)Katie E Archer, Emily E Reid, Manami Shizuka, et al.
Molecular Pharmaceutics|July 10, 2019
A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine ConjugationNicholas C Yoder, Chen Bai, Daniel Tavares, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Synthesis and Evaluation of Camptothecin Antibody-Drug ConjugatesWei Li, Karen H Veale, Qifeng Qiu, et al.
Bioconjugate Chemistry|April 9, 2017
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid ConjugatesXiuxia Sun, Jose F Ponte, Nicholas C Yoder, et al.
Molecular Cancer Therapeutics|August 14, 2020
Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived XenograftsAdnan O Abu-Yousif, Donna Cvet, Melissa Gallery, et al.
Molecular Cancer Therapeutics|February 15, 2018
A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs)Michael L Miller, Manami Shizuka, Alan Wilhelm, et al.
ACS Chemical Biology|August 23, 2012
In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compoundThomas A Keating, Joseph V Newman, Nelson B Olivier, et al.
Journal of Medicinal Chemistry|October 10, 2012
Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK)Gabriel Martínez-Botella, John N Breen, James E S Duffy, et al.
Nature|April 9, 2025
Small molecules restore mutant mitochondrial DNA polymerase activitySebastian Valenzuela, Xuefeng Zhu, Bertil Macao, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
ACS Medicinal Chemistry Letters|August 16, 2019
Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody-Drug Conjugates (ADCs)Katie E Archer, Emily E Reid, Manami Shizuka, et al.
Molecular Pharmaceutics|July 10, 2019
A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine ConjugationNicholas C Yoder, Chen Bai, Daniel Tavares, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Synthesis and Evaluation of Camptothecin Antibody-Drug ConjugatesWei Li, Karen H Veale, Qifeng Qiu, et al.
Bioconjugate Chemistry|April 9, 2017
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid ConjugatesXiuxia Sun, Jose F Ponte, Nicholas C Yoder, et al.
Molecular Cancer Therapeutics|August 14, 2020
Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived XenograftsAdnan O Abu-Yousif, Donna Cvet, Melissa Gallery, et al.
Molecular Cancer Therapeutics|February 15, 2018
A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs)Michael L Miller, Manami Shizuka, Alan Wilhelm, et al.
ACS Chemical Biology|August 23, 2012
In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compoundThomas A Keating, Joseph V Newman, Nelson B Olivier, et al.
Journal of Medicinal Chemistry|October 10, 2012
Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK)Gabriel Martínez-Botella, John N Breen, James E S Duffy, et al.
Nature|April 9, 2025
Small molecules restore mutant mitochondrial DNA polymerase activitySebastian Valenzuela, Xuefeng Zhu, Bertil Macao, et al.
Pageof 3